Giada Bianchi
Director of the Amyloidosis Program, Dana Farber Cancer Institute · Beth Israel Deaconess Medical Center
Credentials: · · · · ·
History
- Present
Dana Farber Cancer Institute Center · Beth Israel Deaconess Medical Center
- Present
Beth Israel Deaconess Cancer Center · Beth Israel Deaconess Medical Center
2006–2009
Research
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Clinical Cancer Research · 2015 · 272 citations
Blood · 2010 · 259 citations
Cancer Cell · 2009 · 237 citations
30 papers
25 papers
16 papers
- SC
15 papers · 2 as a fellow
14 papers
- AY
13 papers
13 papers
13 papers
Grants
- 2020–2025
Functional Consequences of Ubiquitin Depletion During B Lymphocyte Differentiation
National Cancer Institute · K08
Contact PI · $1M · Brigham and Women's Hospital
Clinical trials
- 2024–2029
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
Principal investigator · Recruiting · Phase 1, Phase 2
Dana-Farber Cancer Institute